News Release Details

ROCKVILLE, Md.--(BUSINESS WIRE)--Dec. 12, 2011-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will provide a corporate overview presentation, which may include a discussion of recent business developments, preliminary 2011 financial results and financial guidance for full year 2012, at the following investor conferences during January 2012:

• 30^th Annual J.P. Morgan Healthcare Conference
  San Francisco, CA
  January 10, 2012
  11:00 AM Pacific

• BOCEMb 2012 Noble Financial Capital Markets 8^th Annual Equity Conference
  Ft. Lauderdale, FL
  January 17, 2012
  2:30 PM Eastern

Webcasts of these presentations will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.

Source: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com